Melanie Kahle

Addition of a dipeptidyl peptidase‐4 inhibitor, sitagliptin, to ongoing therapy with the glucagon‐like peptide‐1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes

J. Holst, M. Kahle, M. Nauck, 2017, Diabetes, obesity & metabolism.